Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-11-29

Clinical Trial Update: TRYHARD: Radiation Therapy Plus Cisplatin With or Without Lapatinib in Treating Patients With Head and Neck Cancer. [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating radiation therapy plus cisplatin with or without lapatinib in non-HPV locally advanced head and neck cancer; completed with posted resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CISPLATIN (cisplatin)
  • Lapatinib (Lapatinib)
  • Radiation therapy

Snippet

Sponsor: Radiation Therapy Oncology Group | Conditions: Non-HPV Locally Advanced Head and Neck Cancer | Phase 2 | Status: COMPLETED | Results posted: 2021-11-29